Propylene Glycols

• 

  Subject Areas on Research

  • An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trials. 
  • Bayesian latent variable models for mixed discrete outcomes. 
  • Early estrogen action: concomitant stimulations within two minutes of nuclear RNA synthesis and uptake of RNA precursor by the uterus. 
  • Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity. 
  • Efficacy of felbamate in therapy for partial epilepsy in children. 
  • Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivo. 
  • FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. 
  • In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator. 
  • Measurement of felbamate by wide-bore capillary gas chromatography and flame ionization detection. 
  • Modulation of adaptive immune responses by sphingosine-1-phosphate. 
  • Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. 
  • Range of the solvation pressure between lipid membranes: dependence on the packing density of solvent molecules. 
  • S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection. 
  • Should we B-leavin' now? 
  • Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. 
  • The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. 
  • The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. 
  • Vaginal distribution of Replens and K-Y Jelly using three imaging techniques. 
• 

  Keywords of People

  • Gunn, Michael Dee, Professor of Medicine, Immunology